Abbott Laboratories EBIT Margin 2010-2025 | ABT
Current and historical EBIT (Earnings Before Interest & Taxes) margin for Abbott Laboratories (ABT) over the last 10 years. The current EBIT profit margin for Abbott Laboratories as of March 31, 2025 is .
| Abbott Laboratories EBIT Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBIT | EBIT Margin |
| 2025-03-31 | $42.34B | $7.13B | 16.84% |
| 2024-12-31 | $41.95B | $6.83B | 16.27% |
| 2024-09-30 | $41.22B | $6.69B | 16.24% |
| 2024-06-30 | $40.73B | $6.48B | 15.92% |
| 2024-03-31 | $40.33B | $6.36B | 15.76% |
| 2023-12-31 | $40.11B | $6.48B | 16.15% |
| 2023-09-30 | $39.96B | $6.00B | 15.02% |
| 2023-06-30 | $40.23B | $6.13B | 15.23% |
| 2023-03-31 | $41.51B | $6.96B | 16.77% |
| 2022-12-31 | $43.65B | $8.36B | 19.16% |
| 2022-09-30 | $45.03B | $9.44B | 20.95% |
| 2022-06-30 | $45.55B | $10.21B | 22.42% |
| 2022-03-31 | $44.51B | $9.23B | 20.73% |
| 2021-12-31 | $43.08B | $8.43B | 19.56% |
| 2021-09-30 | $42.31B | $8.48B | 20.04% |
| 2021-06-30 | $40.23B | $7.43B | 18.46% |
| 2021-03-31 | $37.34B | $6.71B | 17.97% |
| 2020-12-31 | $34.61B | $5.36B | 15.48% |
| 2020-09-30 | $32.22B | $4.31B | 13.39% |
| 2020-06-30 | $31.44B | $4.02B | 12.78% |
| 2020-03-31 | $32.10B | $4.55B | 14.18% |
| 2019-12-31 | $31.90B | $4.53B | 14.21% |
| 2019-09-30 | $31.36B | $4.31B | 13.74% |
| 2019-06-30 | $30.94B | $4.11B | 13.27% |
| 2019-03-31 | $30.72B | $3.78B | 12.31% |
| 2018-12-31 | $30.58B | $3.65B | 11.94% |
| 2018-09-30 | $30.40B | $3.14B | 10.32% |
| 2018-06-30 | $29.58B | $2.91B | 9.84% |
| 2018-03-31 | $28.45B | $2.41B | 8.49% |
| 2017-12-31 | $27.39B | $1.56B | 5.71% |
| 2017-09-30 | $25.13B | $1.70B | 6.77% |
| 2017-06-30 | $23.61B | $1.83B | 7.75% |
| 2017-03-31 | $22.30B | $2.26B | 10.13% |
| 2016-12-31 | $20.85B | $3.03B | 14.51% |
| 2016-09-30 | $20.71B | $3.05B | 14.74% |
| 2016-06-30 | $20.56B | $2.87B | 13.95% |
| 2016-03-31 | $20.39B | $2.78B | 13.64% |
| 2015-12-31 | $20.41B | $2.87B | 14.05% |
| 2015-09-30 | $20.57B | $2.88B | 14.00% |
| 2015-06-30 | $20.50B | $2.90B | 14.13% |
| 2015-03-31 | $20.39B | $2.84B | 13.95% |
| 2014-12-31 | $20.25B | $2.60B | 12.84% |
| 2014-09-30 | $18.90B | $2.19B | 11.58% |
| 2014-06-30 | $18.65B | $1.93B | 10.37% |
| 2014-03-31 | $19.03B | $1.88B | 9.89% |
| 2013-12-31 | $19.66B | $2.13B | 10.85% |
| 2013-09-30 | $18.84B | $1.69B | 8.98% |
| 2013-06-30 | $19.28B | $1.53B | 7.93% |
| 2013-03-31 | $19.14B | $1.47B | 7.66% |
| 2012-12-31 | $19.05B | $1.36B | 7.14% |
| 2012-09-30 | $26.24B | $3.47B | 13.21% |
| 2012-06-30 | $30.79B | $3.75B | 12.18% |
| 2012-03-31 | $35.09B | $4.96B | 14.13% |
| 2011-12-31 | $38.85B | $5.75B | 14.80% |
| 2011-09-30 | $38.44B | $5.50B | 14.30% |
| 2011-06-30 | $37.30B | $6.09B | 16.31% |
| 2011-03-31 | $36.51B | $5.92B | 16.21% |
| 2010-12-31 | $35.17B | $6.09B | 17.31% |
| 2010-09-30 | $33.99B | $6.12B | 18.01% |
| 2010-06-30 | $33.08B | $6.58B | 19.89% |
| 2010-03-31 | $31.74B | $6.65B | 20.93% |
| 2009-12-31 | $30.76B | $6.24B | 20.27% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $233.799B | $41.950B |
| Abbott Labs discovers, develops, manufactures & sells a diversified line of health care products. Established Pharmaceuticals Division includes branded generics business in the emerging markets. Medical Devices unit includes the diabetes care, vision care & vascular businesses. Diagnostics unit manufactures and markets diagnostic systems and tests in four business lines core laboratory, molecular, point of care and rapid diagnostics. Nutrition unit includes a broad line of pediatric and adult nutritional products. Abbott acquired CFR Pharmaceuticals, Tendyne Holdings, Inc., St. Jude Medical and Alere Inc. On the other hand, Abbott sold its developed markets branded generics pharmaceuticals business to Mylan. Abbott retained the branded generics pharmaceuticals business in emerging markets. Abbott sold its animal health business to Zoetis Inc and divested its vision care business, Medical Optics, to Johnson & Johnson. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boston Scientific (BSX) | United States | $157.605B | 39.46 |
| Stryker (SYK) | United States | $150.214B | 31.41 |
| EssilorLuxottica (ESLOY) | France | $126.765B | 0.00 |
| Medtronic (MDT) | Ireland | $110.324B | 15.64 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.804B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.676B | 26.62 |
| ResMed (RMD) | United States | $37.413B | 28.10 |
| GE HealthCare Technologies (GEHC) | United States | $34.057B | 16.17 |
| Agilent Technologies (A) | United States | $33.852B | 22.07 |
| Terumo (TRUMY) | Japan | $27.835B | 36.15 |
| Koninklijke Philips (PHG) | Netherlands | $23.245B | 16.31 |
| Insulet (PODD) | United States | $22.033B | 86.49 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.095B | 11.62 |
| Baxter (BAX) | United States | $15.595B | 11.64 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.236B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.639B | 23.10 |
| Lantheus Holdings (LNTH) | United States | $5.638B | 14.22 |
| Prestige Consumer Healthcare (PBH) | United States | $3.998B | 17.86 |
| Perrigo (PRGO) | Ireland | $3.649B | 9.25 |
| Haemonetics (HAE) | United States | $3.545B | 16.15 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.244B | 23.92 |
| QuidelOrtho (QDEL) | United States | $1.952B | 13.43 |
| LeMaitre Vascular (LMAT) | United States | $1.866B | 41.70 |
| AtriCure (ATRC) | United States | $1.598B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.289B | 13.08 |
| Acuren (TIC) | United States | $1.271B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.111B | 25.00 |
| Phibro Animal Health (PAHC) | United States | $1.040B | 13.30 |
| Neogen (NEOG) | United States | $1.027B | 13.14 |
| BioLife Solutions (BLFS) | United States | $1.021B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $0.907B | 0.00 |
| InMode (INMD) | Israel | $0.897B | 9.04 |
| Owens & Minor (OMI) | United States | $0.685B | 5.69 |
| CeriBell (CBLL) | United States | $0.683B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.629B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.531B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.509B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Surmodics (SRDX) | United States | $0.412B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.403B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.354B | 13.00 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.323B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 23.07 |
| Cerus (CERS) | United States | $0.271B | 0.00 |
| ZimVie (ZIMV) | United States | $0.258B | 11.72 |
| Sanuwave Health (SNWV) | United States | $0.256B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.253B | 0.00 |
| Brainsway (BWAY) | Israel | $0.250B | 66.10 |
| Cresco Labs (CRLBF) | United States | $0.246B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.233B | 69.17 |
| Biote (BTMD) | United States | $0.230B | 6.46 |
| OraSure Technologies (OSUR) | United States | $0.225B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.201B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.188B | 15.29 |
| Omeros (OMER) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.184B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.177B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.144B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.120B | 14.81 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.092B | 11.90 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.082B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| Zynex (ZYXI) | United States | $0.077B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.077B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.077B | 0.00 |
| MacroGenics (MGNX) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| ImmuCell (ICCC) | United States | $0.061B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.057B | 0.00 |
| Nephros (NEPH) | United States | $0.041B | 55.14 |
| United-Guardian (UG) | United States | $0.037B | 12.94 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Safety Shot (SHOT) | United States | $0.023B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |